表紙:マウスモデル技術の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測
市場調査レポート
商品コード
1342841

マウスモデル技術の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測

Global Mice Model Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日: | 発行: Value Market Research | ページ情報: 英文 147 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
マウスモデル技術の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 147 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マウスモデル技術市場の世界需要は、2022年の50億4,000万米ドルから2030年には125億2,000万米ドル近くの市場規模に達すると推定され、調査期間2023~2030年のCAGRは10.64%です。

マウスモデル技術は、ヒトに見られる生物学的プロセスや疾患の特徴を模倣するために、異なる種のマウスを使用します。マウスはヒトと同じ哺乳類の特徴を持ち、多くの類似した病気に罹患するため、これらの技術は普及しています。マウスモデル技術は生物医学研究に非常に有益です。遺伝子工学は、特定のヒトの病態をターゲットとする様々なタイプのモデルマウスを開発するために使用されます。

市場力学:

遺伝子編集ツールの進歩と人間とマウスの生理学的類似性がマウスモデル技術の需要を拡張する主な要因です。一方、さまざまな政府による厳しい規制やガイドライン、いくつかの団体によるマウス実験への反対運動の高まりは、市場の拡大を制限する可能性があります。それにもかかわらず、ヒト化マウスモデルに対する需要の高まりと個別化医療の消費の増加は、マウスモデル技術市場にプラスの影響を与える可能性が高いです。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはマウスモデル技術の世界市場における各セグメントを包括的に評価することもできます。マウスモデル技術産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析:

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東&アフリカにおけるマウスモデル技術市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、このレポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 マウスモデル技術-産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 マウスモデル技術の世界市場分析:技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • CRISPRノックアウト
  • CRISPRノックイン
  • ランダム挿入
  • 大規模ターゲット挿入
  • ES細胞改変(相同組換え)
  • その他

第7章 マウスモデル技術の世界市場分析:エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 製薬企業
  • バイオテクノロジー企業
  • 学術・研究施設
  • 研究・製造受託機関

第8章 マウスモデル技術の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 マウスモデル技術企業の競合情勢

  • マウスモデル技術市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Biocytogen
  • Charles River Laboratories
  • Cyagen Biosciences
  • Gempharmatech
  • genOway
  • ingenious targeting laboratory
  • Merck KGaA
  • Ozgene Pty Ltd.
  • Taconic Biosciences Inc.
  • PolyGene AG
  • The Jackson laboratory
  • Yale School of Medicine
  • University of North Carolina
  • University of Nebraska Medical Center
  • Monash University
  • UMass Chan Medical School
  • University of Bonn
  • Columbia University
  • The University of Arizona
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Technology (USD MN)
  • CRISPR Knockout Market Sales by Geography (USD MN)
  • CRISPR Knockin Market Sales by Geography (USD MN)
  • Random Insertions Market Sales by Geography (USD MN)
  • Large, Targeted Insertions Market Sales by Geography (USD MN)
  • ES Cell Modification (Homologous Recombination) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-user (USD MN)
  • Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic And Research Facilities Market Sales by Geography (USD MN)
  • Contract Research And Manufacturing Organizations Market Sales by Geography (USD MN)
  • Global Mice Model Technologies Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Mice Model Technologies Report
  • Market Research Process
  • Market Research Methodology
  • Global Mice Model Technologies Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Technology (USD MN)
  • CRISPR Knockout Market Sales by Geography (USD MN)
  • CRISPR Knockin Market Sales by Geography (USD MN)
  • Random Insertions Market Sales by Geography (USD MN)
  • Large, Targeted Insertions Market Sales by Geography (USD MN)
  • ES Cell Modification (Homologous Recombination) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic And Research Facilities Market Sales by Geography (USD MN)
  • Contract Research And Manufacturing Organizations Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219536

The global demand for Mice Model Technologies Market is presumed to reach the market size of nearly USD 12.52 BN by 2030 from USD 5.04 BN in 2022 with a CAGR of 10.64% under the study period 2023 - 2030.

Mice model technologies use different mice species in order to mimic characteristics of a biological process or a disease found in humans. These technologies have become popular because mice share mammalian features with humans and suffer from many similar diseases. Mice model technologies are highly beneficial for biomedical research. Genetic engineering is used to develop different types of mice models to target specific human conditions.

MARKET DYNAMICS:

The rise in the advancements in gene editing tools and physiological similarities between humans and mice are major factors augmenting the demand for mice model technologies. On the downside, strict regulations and guidelines imposed by various governments and growing opposition to mice testing by several organizations may restrict market expansion. Nonetheless, rising demand for humanized mouse models and increasing consumption of personalized medicine will likely impact the mice model technologies market positively.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mice model technologies. The growth and trends of mice model technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mice model technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • CRISPR Knockout
  • CRISPR Knockin
  • Random Insertions
  • Large, Targeted Insertions
  • ES Cell Modification (Homologous Recombination)
  • Others

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic And Research Facilities
  • Contract Research And Manufacturing Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Mice Model Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mice model technologies market include Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd., Taconic Biosciences Inc., PolyGene AG, The Jackson laboratory, Yale School of Medicine, University of North Carolina, University of Nebraska Medical Center, Monash University, UMass Chan Medical School, University of Bonn, Columbia University, The University of Arizona. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MICE MODEL TECHNOLOGIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By End-user
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 CRISPR Knockout Historic and Forecast Sales by Regions
  • 6.5 CRISPR Knockin Historic and Forecast Sales by Regions
  • 6.6 Random Insertions Historic and Forecast Sales by Regions
  • 6.7 Large, Targeted Insertions Historic and Forecast Sales by Regions
  • 6.8 ES Cell Modification (Homologous Recombination) Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
  • 7.5 Biotechnology Companies Historic and Forecast Sales by Regions
  • 7.6 Academic And Research Facilities Historic and Forecast Sales by Regions
  • 7.7 Contract Research And Manufacturing Organizations Historic and Forecast Sales by Regions

8 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICE MODEL TECHNOLOGIES COMPANIES

  • 9.1. Mice Model Technologies Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF MICE MODEL TECHNOLOGIES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Biocytogen
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Charles River Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Cyagen Biosciences
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Gempharmatech
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. genOway
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. ingenious targeting laboratory
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Merck KGaA
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Ozgene Pty Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Taconic Biosciences Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. PolyGene AG
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. The Jackson laboratory
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Yale School of Medicine
    • 10.14.1. Company Overview
    • 10.14.2. Company Revenue
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. University of North Carolina
    • 10.15.1. Company Overview
    • 10.15.2. Company Revenue
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. University of Nebraska Medical Center
    • 10.16.1. Company Overview
    • 10.16.2. Company Revenue
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. Monash University
    • 10.17.1. Company Overview
    • 10.17.2. Company Revenue
    • 10.17.3. Products
    • 10.17.4. Recent Developments
  • 10.18. UMass Chan Medical School
    • 10.18.1. Company Overview
    • 10.18.2. Company Revenue
    • 10.18.3. Products
    • 10.18.4. Recent Developments
  • 10.19. University of Bonn
    • 10.19.1. Company Overview
    • 10.19.2. Company Revenue
    • 10.19.3. Products
    • 10.19.4. Recent Developments
  • 10.20. Columbia University
    • 10.20.1. Company Overview
    • 10.20.2. Company Revenue
    • 10.20.3. Products
    • 10.20.4. Recent Developments
  • 10.21. The University of Arizona
    • 10.21.1. Company Overview
    • 10.21.2. Company Revenue
    • 10.21.3. Products
    • 10.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies